Morgan Stanley Liva Nova PLC Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
A detailed history of Morgan Stanley transactions in Liva Nova PLC stock. As of the latest transaction made, Morgan Stanley holds 283,096 shares of LIVN stock, worth $15.3 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
283,096
Previous 223,113
26.88%
Holding current value
$15.3 Million
Previous $8.76 Million
45.43%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding LIVN
# of Institutions
273Shares Held
55.5MCall Options Held
75.5KPut Options Held
73.1K-
Black Rock Inc. New York, NY6.9MShares$374 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA4.64MShares$251 Million0.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$133 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.43MShares$131 Million0.06% of portfolio
-
State Street Corp Boston, MA2.08MShares$113 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.9B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...